Resources:
The need for an EU Real-World Evidence (RWE) Generation Action Plan was a key conclusion from the 2020 RWE4Decisions Conference held under the auspices of the German EU Presidency. This call was taken up in the June EPSCO Council Conclusions on Access to Medicines under the Portuguese EU Presidency.
Over the past year, RWE4Decisions has held payer-led multi-stakeholder workshops on outcomes-based managed entry agreements, seeking to align data collection requirements and identify appropriate sources to resolve decision-relevant uncertainties as outlined in the TRUST4RD tool and RWE4Decisions stakeholder actions.
RWE4Decisions shared recommendations on how an EU RWE Generation Action Plan, defined through multi-stakeholder collaboration, can guide payers and HTA decision-makers, as well as industry, on the data required to address uncertainties at the time of launch of potentially transformative therapies for patients.
Public Webinar: From Policy to Practice: EHDS Implementation to Support Better Real-World Evidence for HTA/Payers
RWE4Decisions Symposium: Developing Real-World Evidence to Deliver Innovation in HTA
Public Webinar: HTA/Payer Collaboration in the Nordics: The Role of Real-World Evidence
